GlassScriptPhysician profile
Nicholas S Howell
NPI 1649570029
$1,345.41
in general payments reported to CMS, 2019-2025
16 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $125 · 2023: $493 · 2024: $264 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $191.81 | 2023-2025 | Repatha |
| Edwards Lifesciences Corporation | $190.49 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $180.35 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $168.84 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.76 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.64 | 2021-2025 | Lifevest |
| Pfizer INC. | $57.73 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $53.56 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $40.78 | 2021-2022 | |
| Abbott Laboratories | $39.10 | 2023 | Assurity |
| Philips North America LLC | $37.68 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Dd1) Duo Hybrid |
| Lexicon Pharmaceuticals, INC. | $37.36 | 2024 | |
| Esperion Therapeutics, INC. | $32.17 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.59 | 2023 | |
| Bridgebio Pharma, INC. | $22.56 | 2025 | Attruby |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.